Benzodiazepine Tapering: a Step-By-Step Approach for Patients

How does a person taper off a benzodiazepine safely?

A benzodiazepine is tapered by lowering the dose in small steps over months, with a pause whenever symptoms rise, at a pace the patient sets together with the prescriber. The dose is steadied, a plan is agreed, each reduction is followed by a hold, and the last step is planned as carefully as the first.

Many people come to this subject by searching for a benzo detox. The word suggests something quick. Safe discontinuation is the opposite: a gradual, medically supervised taper that takes months, sometimes longer, and happens at home in the middle of ordinary life.

The steps below follow the Ashton Manual, written by Professor C. Heather Ashton, and the Maudsley Deprescribing Guidelines. These are the frameworks that Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, works from.

Why does a prescribed dose cause physical dependence?

Benzodiazepines such as alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) strengthen the effect of gamma-aminobutyric acid (GABA), the brain’s main calming signal. With daily use, the nervous system adapts. GABA receptors become less responsive, and the brain comes to count on the medication to keep its excitatory systems in check.

That adaptation is physical dependence, and it happens to people who take the medication exactly as directed. The United States Food and Drug Administration (FDA) said so in its 2020 boxed warning update for the whole drug class. Physical dependence can occur after several days to weeks of steady use, even as prescribed.

Physical dependence is not addiction. The idea that the two are the same is one of the common myths about coming off benzodiazepines. In fact, a person who takes a prescribed dose and feels unwell when it is lowered has a medical condition caused by the medication. The treatment that fits is a gradual taper, not a program designed for compulsive drug use.

Tolerance often arrives alongside dependence, so the same dose does less over time. The z-drugs, such as zolpidem (Ambien), act on the same receptors and are tapered on the same principles.

Why is stopping suddenly dangerous?

When the medication is removed all at once, everything it was holding down rebounds. Chapter III of the Ashton Manual describes that rebound as an overactivity of all the systems the drug had been damping. The result can be severe anxiety, insomnia, tremor, and, in the worst cases, a seizure.

The FDA’s 2020 update carries the same warning. Stopping abruptly, or reducing the dose too quickly, can cause withdrawal reactions, including seizures, that can be life-threatening. A seizure, or any other medical emergency, means calling 911 right away.

So, cold turkey is not a tapering method. Neither is a rapid reduction squeezed into a short facility stay. There is also kindling, a pattern in which each abrupt withdrawal appears to leave the nervous system more sensitive to the next one.

Fortunately, the adaptation runs in both directions. When the dose comes down in small steps, GABA receptors have time to recalibrate between reductions. That is why slow works. Chapter III stresses that withdrawal symptoms can be minimized and largely avoided by slow tapering tailored to the person.

First, the dose is steadied and the groundwork is laid.

No reduction starts from an unstable dose. The medication is taken the same way, at the same times, every day until symptoms are as steady as they are going to be.

Chapter II of the Manual has a section on what to do before starting, and its first instruction is to consult the doctor and the pharmacist. The prescriber’s agreement and cooperation are necessary.

The planning visit is a consent conversation as well. It covers the risks of tapering and the risks of staying on the medication, the alternatives, where the taper is expected to end, and the patient’s right to slow down, pause, or decline.

The rest of the groundwork is practical. A patient writes down the current dose and times, starts a short daily symptom diary so there is a baseline, tells one trusted person about the plan, and settles sleep, meals, and caffeine into a routine. It also helps to expect months, not weeks, and progress that does not run in a straight line.

Second, the schedule is built for one person from two frameworks.

For short-acting medications such as alprazolam or lorazepam, Chapter II describes a crossover to diazepam, substituted one dose at a time. Diazepam leaves the body slowly and comes in small strengths, which is why the Manual recommends the switch. A crossover taper is a tool. It is not a requirement, and some patients taper their own medication directly, often as a liquid.

Then come the reductions. The Manual suggests lowering the dose by up to one tenth at each step, with one to two weeks between steps, and with smaller steps as the dose falls. Yet, the words “up to” matter. Professor Ashton wrote that the patient must be in control of the pace.

The Maudsley Deprescribing Guidelines add the hyperbolic principle. Each reduction is sized as a proportion of the current dose, not the starting dose, because the last small amounts of the medication do far more at the receptor than their size suggests. The shape is a landing: the descent can be steeper at altitude, and it flattens as the ground gets close.

Unfortunately, no chart can do this part for a patient. These are frameworks. Neither one is a schedule to copy, and the FDA’s 2020 update says that no standard tapering schedule suits every patient. The actual steps are worked out with the prescriber, for one person, and they change as the taper goes on.

Third, each reduction is followed by a hold.

After a step down, the dose stays where it is until the nervous system catches up. Symptoms in the days after a cut are that system readjusting.

The diary earns its keep here. A few lines a day show whether symptoms are settling or building, and they give the prescriber something better than memory to work with. If symptoms have not settled, the next step waits.

What happens when a cut turns out to be too large? The Manual advises standing still for a few weeks and, as far as possible, not going backwards. A hold is usually the first move. Dr. Leeds also regards a small updose after a cut that proves too large as a legitimate adjustment.

Neither a hold nor an updose is a failure. In fact, the pace of the taper is the main tool a patient has for coping with withdrawal, and slowing down is using it.

What helps on the hard days between reductions?

Nothing replaces the pace, and the evidence for most self-care measures is limited. Still, patients commonly describe a few things that make the bad days of a taper more bearable.

For anxiety, it is slow breathing and a short walk. For insomnia, it is a fixed bedtime and wake time and less caffeine. For muscle tension it is heat and gentle stretching, for mood swings a simple routine, and for an upset stomach small plain meals and plenty of fluids.

Questions about supplements, antihistamines, and other remedies are settled one patient at a time, with a physician who understands the pharmacology. Responses vary, the evidence is thin, and none of them substitutes for a gradual taper.

Withdrawal also pushes people away from other people. Shame, anxiety, and sensitivity to noise and light make it tempting to cancel everything, yet isolation tends to make symptoms worse. Small, low-demand contact is enough: a short call, a walk with one person, a family member who understands that a prescription caused this. Peer groups and online communities can help as well, although they are not medical care.

Symptoms that feel unsafe are a reason to call the prescriber the same day. Thoughts of suicide mean calling or texting 988, or calling 911.

Fourth, the last step should feel like just another step.

How does a taper end? Chapter II of the Ashton Manual advises stopping once the dose reaches 0.5 mg of diazepam a day. That advice reflected the scored tablets Professor Ashton taught from, which can only be divided so far, and it remains an option for a patient who is doing well and chooses it.

However, Dr. Leeds does not use it as the default. With the manufactured 1 mg/mL diazepam oral solution, he keeps reducing below 0.5 mg, in steps sized to the remaining dose, and stops at about 0.1 mg. The stopping point is agreed in advance, and the aim is plain: the final step should be no bigger an event than the ones before it.

Near the bottom, a small amount of medication is still doing real work at the receptor. How low a taper should go deserves its own conversation with the prescriber, and these figures are not a schedule for anyone to follow alone.

After the last dose, symptoms come in windows and waves.

Is the taper over when the last dose is taken? Not quite. Chapter III of the Manual describes symptoms that wax and wane, with “windows” of feeling normal that grow longer and more frequent while the waves fade.

The same chapter says that with slow tapering, symptoms disappear within a few months for the majority. A minority have symptoms that persist for a year or more, known as protracted withdrawal. Fortunately, even those symptoms tend to ease with time.

A wave weeks after the last dose is usually the nervous system still settling. It does not mean the original anxiety or insomnia has returned, and it does not mean the taper was a mistake. It is a reason to talk with the prescriber. The nervous system adapted to the medication slowly, and it adapts to its absence the same way.

What else do patients ask about tapering?

How long does it take to taper off a benzodiazepine?

Months, and often more than a year. Chapter II of the Manual says that whether a taper takes 6, 12, or 18 months is of little significance. The length is set by how each step is tolerated.

What if a prescriber wants the taper to go faster?

The patient is allowed to say no. Chapter II tells patients not to let a doctor impose a deadline, and Dr. Leeds holds the same view. The doctor’s job is to advise slowing down when a taper is too fast, and going faster is something patient and doctor agree on, as tolerated.

Where does Dr. Leeds’ practice fit?

BenzoDoc is the website of Dr. Leeds’ medical practice in Fort Lauderdale, Florida. He is one physician who works directly with each patient, by telemedicine throughout Florida, on a concierge basis and not through insurance. The practice’s primary service is medically supervised benzodiazepine and z-drug tapering, paced by the patient. Contact the office through the contact form to ask about a supervised taper in Florida.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.